Is DocuSign Stock Undervalued?
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-08-31 | 2024-08-31 | 2025-08-31 | 2024-08-31 | 2025-08-31 | |
| Income Statement | ||||||
| Revenue | $41M | $46.3M | $44.6M | $11.6M | $9.9M | |
| Gross Profit | $17.1M | $22M | $20.4M | $5.5M | $4.4M | |
| Operating Income | $7.6M | $10.5M | $9M | $2.9M | $2.2M | |
| EBITDA | $9.2M | $12.1M | $10.8M | $3.3M | $2.7M | |
| Diluted EPS | $2.03 | $2.84 | $2.71 | $0.86 | $0.70 | |
| Period Ending | 2021-08-31 | 2022-08-31 | 2023-08-31 | 2024-08-31 | 2025-08-31 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $33.7M | $37.8M | $46.8M | $48M | $55.6M | |
| Total Assets | $45.6M | $49.4M | $60.3M | $61.9M | $70.3M | |
| Current Liabilities | $4.6M | $5.1M | $8.3M | $8M | $6M | |
| Total Liabilities | $4.6M | $5.1M | $8.3M | $8M | $6M | |
| Total Equity | $41M | $44.3M | $51.9M | $53.9M | $64.3M | |
| Total Debt | -- | -- | -- | -- | -- | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-08-31 | 2024-08-31 | 2025-08-31 | 2024-08-31 | 2025-08-31 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $10.8M | $6.6M | $11.5M | -$3.6M | $483.6K | |
| Cash From Investing | -$29.7M | $1.6M | -$11.7M | $2.9M | $461.8K | |
| Cash From Financing | $100.6K | -$8.9M | $167.9K | $11K | $16.9K | |
| Free Cash Flow | $7.8M | $5.3M | $9M | -$3.8M | $298.6K | |
Taylor Devices, Inc. engages in the design, development, manufacture, and marketing of shock absorption, rate control, and energy storage devices. Its products include metal bellows dampers, fluid viscous dampers, landing and arresting gear, pumpkin mounts, isolation systems, custom applications, crane buffers, shock absorbers, liquid die springs, lock up devices, machined springs, and actuators. The company was founded by Paul H. Taylor on July 22, 1955 and is headquartered in North Tonawanda, NY.
In the current month, TAYD has received 1 Buy ratings 0 Hold ratings, and 0 Sell ratings. The TAYD average analyst price target in the past 3 months is $48.00.
According to analysts, the consensus estimate is that Taylor Devices, Inc. share price will drop to $48.00 per share over the next 12 months.
Analysts are divided on their view about Taylor Devices, Inc. share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Taylor Devices, Inc. is a Sell and believe this share price will rise from its current level to $48.00.
The price target for Taylor Devices, Inc. over the next 1-year time period is forecast to be $48.00 according to 1 Wall Street analyst, 1 of them rates the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
According to Wall Street analysts, the consensus rating for Taylor Devices, Inc. is a Buy. 1 of 1 analysts rates the stock a Buy at this time.
You can purchase shares of Taylor Devices, Inc. via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Taylor Devices, Inc. shares.
Taylor Devices, Inc. was last trading at $61.74 per share. This represents the most recent stock quote for Taylor Devices, Inc.. Yesterday, Taylor Devices, Inc. closed at $61.74 per share.
In order to purchase Taylor Devices, Inc. stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
Signup to receive the latest stock alerts
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…
Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…
Market Cap: $4.6T
P/E Ratio: 64x
Market Cap: $4T
P/E Ratio: 37x
Market Cap: $3.8T
P/E Ratio: 39x
Hut 8 Corp. [HUT] is up 0.65% over the past day.
Travere Therapeutics, Inc. [TVTX] is up 14.03% over the past day.
Structure Therapeutics, Inc. [GPCR] is down 2.36% over the past day.